CBDA, or cannabidiolic acid, is a precursor molecule to CBD, or cannabidiol, a cannabinoid of ever-increasing importance for medical cannabis patients. Like CBD, CBDA has no known psychoactive effects. However, unlike CBD, cannabidiolic acid is found in abundance in fresh cannabis, that is, cannabis that has not been heated to trigger decarboxylation.

CBDA - Chemical Structure

Chemical structure of cannabidiolic acid

At Tilray, any strain or House Blend labelled +CBD is rich in CBDA before decarboxylation. Tilray Drops, however, are already decarboxylated so they contain negligible amounts of cannabidiolic acid. See our available +CBD strains and House Blends here.

CBDA Medical Research

As is the case with other compounds produced in cannabis, medical research has begun into its therapeutic potential, which presents differences from those of CBD. Below are links to recently published research into this important chemical compound.
Anti-bacterial: The Composition of Hemp Seed Oil and its Potential as an Important Source of Nutrition
Cancer: DNA microarray analysis of genes in highly metastatic 4T1E/M3 murine breast cancer cells following exposure to cannabidiolic acid
Inflammation: Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa
Nausea: Effect of combined oral doses of Δ9-tetrahydrocannabinol and cannabidiolic acid on acute and anticipatory nausea in rat models